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Supplementary Figure 1. In-vivo capture data for both control (no device) and IONP-HN3-
DNA coated device. 
 
Supplementary Figure 2. Full ATR-IR spectrum of magnetite, genomic DNA, and DNA-
functionalized particles (IONP-HN3-DNA and IONP-Pt-DNA). 
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Supplementary Figure 3. ATR-IR spectrum (1800-400 cm-1) of magnetite, genomic DNA, 
and DNA-functionalized particles [IONP-HN3-DNA and IONP-Pt-DNA].1 
 
 
 
 
 
Supplementary Figure 4. Reduction of cisplatin concentration over time due to capture by 
IONP-HN3-DNA particles, as characterized by ICP-MS. Cisplatin solution (20 mL, 0.05 
mg/mL) with 100 mg IONP-HN3-DNA. Average of three runs (error bars = 1 standard 
deviation). 
 
 
Supplementary Figure 5. Reduction of EPI concentration over time due to capture by 
IONP-HN3-DNA as characterized by fluorescence measurements. EPI solution (20 mL, 
0.05 mg/mL) with 100 mg IONP-HN3-DNA. Average of three runs (error bars = 1 standard 
deviation). 
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Supplementary Figure 6. DOX capture as a function of particle loading. Average of three 
runs (error bars = 1 standard deviation).  
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Supplementary Figure 7. DOX capture in 10 minutes from human serum (10 mL, 0.05 
mg/mL, 37 °C) as a function of amount of IONP-HN3-DNA added. Average of 3 runs, 
error bars = 1 standard deviation. 
 
 
 
 
Supplementary Figure 8. DOX capture in 7 minutes from human serum (10 mL, 0.05 
mg/mL, 37 °C) as a function of amount of IONP-HN3-DNA added. Average of 3 runs, 
error bars = 1 standard deviation. 
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Supplementary Figure 9. DOX capture in 4 minutes from human serum (10 mL, 0.05 
mg/mL, 37 °C) as a function of amount of IONP-HN3-DNA added. Average of 3 runs, 
error bars = 1 standard deviation. 
 
 
 
Supplementary Figure 10. DOX capture in 2 minutes from human serum (10 mL, 0.05 
mg/mL, 37 °C) as a function of amount of IONP-HN3-DNA added. Average of 3 runs, 
error bars = 1 standard deviation. 
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Supplementary Figure 11. DOX capture in 1 minute from human serum (10 mL, 0.05 
mg/mL, 37 °C) as a function of amount of IONP-HN3-DNA added. Average of 3 runs, 
error bars = 1 standard deviation. 
 
 
Supplementary Figure 12. SEM image of Fe3O4 particles. Scale bar = 200 nm.  
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Supplementary Figure 13. SEM image of Fe3O4 particle aggregates. Scale bar = 1 μm.  
 
 
Supplementary Figure 14. EDS map and spectrum of Fe3O4 particle aggregates.  
Scale bar = 5 μm.  
 
Supplementary Figure 15. EDS element maps of Fe3O4 particle aggregates.  
Scale bar = 5 μm.  
 
 
 
 
Supplementary Figure 16. SEM image of IONP-HN3-DNA. Scale bar = 100 nm.  
 
 
Supplementary Figure 17. SEM image of IONP-HN3-DNA aggregates. Scale bar = 1 μm.  
 
 
Supplementary Figure 18. EDS spectrum and map of IONP-HN3-DNA aggregates. 
Scale bar = 5 μm.  
 
 
 
Supplementary Figure 19. EDS element maps of IONP-HN3-DNA aggregates. 
Scale bar = 5 μm.  
 
 
 
Supplementary Figure 20. SEM image of IONP-Pt-DNA. Scale bar  = 100 nm.  
 
 
Supplementary Figure 21. SEM image of IONP-Pt-DNA aggregates. Scale bar = 1 μm.  
 
 
Supplementary Figure 22. EDS map and spectrum of IONP-Pt-DNA aggregates. 
Scale bar = 5 μm.  
 
 
 
 
Supplementary Figure 23. EDS element maps of IONP-Pt-DNA aggregates. 
Scale bar = 5 μm. 
 
 
Supplementary Figure 24. SEM image of IONP-Pt aggregates. Scale bar = 1 μm. 
 
 
 
 Supplementary Figure 25. A. Doxorubicin clearance from porcine blood in closed loop flow 
model.  B. Closed loop flow model design with 25 magnet device within the lumen of the 
flow model. In this model, fluid flow performed the function of mechanical stirring in the 
earlier vial experiments. Both approaches proved sufficient to enable drug capture. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Sample ID %C %H %N 
Sample mass 
(mg) 
Fe3O4 
0.71 0.44 0.02 19.78 
0.44 0.37 0.02 9.267 
Average 0.575 0.405 0.02 14.5235 
Standard 
Deviation 
0.19 0.05 0 - 
IONP-Pt-DNA 
5.27 1 2.15 16.98 
5.28 1.01 2.14 14.91 
Average 5.275 1.005 2.145 15.945 
Standard 
Deviation 
0.007 0.007 0.007 - 
IONP-HN3-DNA 
6.6 0.99 2.64 9.933 
6.51 1.04 2.6 14.67 
Average 6.555 1.015 2.62 12.3015 
Standard 
Deviation 
0.06 0.04 0.03 - 
Herring DNA 
33.81 4.61 14.5 3.666 
33.92 4.66 14.68 7.386 
Average 33.865 4.635 14.59 5.526 
Standard 
Deviation 
0.08 0.04 0.13 - 
 
Supplementary Table 1. Elemental analysis data for all materials. 
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